Cas:124895-57-4 6,7-Bis(benzyloxy)-4-hydroxy-2-naphthoic acid manufacturer & supplier

We serve Chemical Name:6,7-Bis(benzyloxy)-4-hydroxy-2-naphthoic acid CAS:124895-57-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6,7-Bis(benzyloxy)-4-hydroxy-2-naphthoic acid

Chemical Name:6,7-Bis(benzyloxy)-4-hydroxy-2-naphthoic acid
CAS.NO:124895-57-4
Synonyms:6,7-Bis(benzyloxy)-4-hydroxy-2-naphthoic acid
Molecular Formula:C25H20O5
Molecular Weight:400.42300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:626.7ºC at 760 mmHg
Density:N/A
Index of Refraction:1.682
PSA:75.99000
Exact Mass:400.13100
LogP:5.40160

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 6,7-Bis(benzyloxy)-4-hydroxy-2-naphthoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6,7-Bis(benzyloxy)-4-hydroxy-2-naphthoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6,7-Bis(benzyloxy)-4-hydroxy-2-naphthoic acid Use and application,6,7-Bis(benzyloxy)-4-hydroxy-2-naphthoic acid technical grade,usp/ep/jp grade.


Related News: as well as the antibody escape mutants for the current Emergency Use Authorization antibodies. Additionally, IGM-6268 was shown to be highly effective for prophylaxis and treatment in mouse models when administered intranasally. (S)-8-methyl-2-((3-((5-methyl-1H-indol-3-yl)methyl)azetidin-1-yl)methyl)-2,3-dihydro-[1,4]dioxino[2,3-f]quinoline dihydrochloride manufacturers Lonza’s Nansha site is fully integrated within the company’s global manufacturing network. Scientists and engineers based in Nansha focus on API development and manufacturing for customers around the globe. 1-[(Z)-1-Cyano-2-methylsulfanyl-2-(2-oxo-2-phenyl-ethylsulfanyl)-vinyl]-pyridinium; bromide suppliers Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder. methyl N-Boc-(R)-2-(1-naphthyl)glycinate vendor & factory.